This test labels cells whose receptors bind a particular displayed peptide under the assay conditions. It helps identify a binding population that can then be studied for function.
The original peptide-MHC tetramer study made soluble multimeric peptide-display complexes to identify antigen-specific T cells. Binding correlated with cytotoxicity in the tested systems, but those observations are different measurements. The chosen peptide and HLA molecule define which interaction is tested. Detecting multimer-binding cells does not by itself establish natural display of that peptide by a tumor, successful target-cell killing or a clinical treatment effect.
Shares Intracellular cytokine staining, T-cell receptor repertoire sequencing, Flow cytometry (immunophenotyping), Immune measurements and product evidence.
Shares T-cell receptor repertoire sequencing, Immune-cell cytotoxicity assays, Immune measurements and product evidence.
Shares Intracellular cytokine staining, Immune-cell cytotoxicity assays, Immune measurements and product evidence.
Shares Immune-cell cytotoxicity assays, Peptide binding, presentation and immune recognition, Immune measurements and product evidence.
Shares T-cell receptor repertoire sequencing, Immune measurements and product evidence.
Shares Peptide binding, presentation and immune recognition, Immune measurements and product evidence.
Shares Peptide binding, presentation and immune recognition, Immune measurements and product evidence.
Shares Peptide binding, presentation and immune recognition, Immune measurements and product evidence.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/